Alector, Inc. Common Stock

ALECNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
2.54 USD
↗ 0.09 (3.67%)AT CLOSE (03:59 PM EST)
2.46
↘ 0.08 (2.99%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
2.46
↘ 0.08 (2.99%)
🔴Market: CLOSED

Shares of Alector, Inc. Common Stock (ALEC) are trading at $2.54. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (35.3%), a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.59
High?$2.59
Low?$2.30
Prev. Close?$2.45
Volume?1.8M
Avg. Volume?5.6M
VWAP?$2.47
Rel. Volume?0.32x
Bid / Ask
Bid?$2.30 × 3.2K
Ask?$2.54 × 1.9K
Spread?$0.24
Midpoint?$2.42
Valuation & Ratios
Market Cap?378.1M
Shares Out?148.9M
Float?92.3M
Float %?82.7%
P/E Ratio?9.19
P/B Ratio?3.24
EPS?$0.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
103
Market Cap
378.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.alector.com
Listed
2019-02-07
Address
131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-231-5660
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
1
Momentum?
85
Short Sent.?
70
Piotroski F-Score?5/9Mixed
Altman Z-Score?-0.40Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.09%Elevated
Short Interest?8.4M
Days to Cover?3.6
Free Float92.3M
Avg Daily Volume2.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.10Strong
Quick Ratio?4.10Strong
Cash Ratio?2.13Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
93/100
P/E?
Peers
100
S&P
97
9.2CHEAP▾
P/B?
Peers
100
S&P
52
3.24FAIR▾
P/S?
Peers
100
S&P
63
2.18CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
92
7.7CHEAP▾
EV/Sales?
Peers
100
S&P
80
1.74CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
84
35.3%STRONG▾
ROA?
Peers
50
S&P
97
24.8%STRONG▾
Cash Flow & Enterprise
FCF?$-150024000
Enterprise Value?$302.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist